Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity (Q27487377)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity
scientific article

    Statements

    Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Julie H McArthur
    0 references
    Jennifer A Marron
    0 references
    Dennis J Pierro
    0 references
    Alexander C Schmidt
    0 references
    November 2008
    0 references
    79
    0 references
    5
    0 references
    678-84
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit